BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?

We expect BioNTech SE (BNTX) to surpass expectations when it reports first-quarter 2024 results on May 6, before the opening bell.Let’s see how things have shaped up for the quarter to be reported.Factors at PlayBioNTech’s top line currently comprises sales of its mRNA-based COVID-19 vaccine, Comirnaty, developed in partnership with Pfizer (PFE) . The vaccine is approved in several countries and has been a key contributor to BioNTech’s top line.However, following the end of the pandemic, sales of BioNTech/P ...